Non-Contagious Period After Paxlovid (Nirmatrelvir/Ritonavir) for COVID-19
Paxlovid treatment does not establish a specific “non-contagious” day. Non-contagious status is based on the time course of symptoms and fever resolution rather than antiviral use.[1][2]
Criteria for Being Considered Much Less Likely to Be Contagious
After a COVID-19 illness with improving symptoms, contagiousness typically decreases after the first 5 days following symptom onset. [1]
After symptoms have fully resolved, contagiousness is expected to be substantially reduced. [1]
Criteria Used for Isolation/Return to Normal Activities
CDC guidance for respiratory viruses recommends staying away from others while symptoms are present and improving, with added precautions after leaving isolation. [1]
Added precautions after the initial restriction period include taking steps to reduce transmission risk (examples listed by CDC include cleaner air, good hygiene, mask use, and physical distancing). [1]
When Prolonged Infectiousness Should Be Assumed
Some people, including those who are immunocompromised, can shed virus for a longer time. [1]
Practical Time-Based Rule Commonly Used
A patient is typically considered “much less likely to be contagious” after the initial 5-day period has passed in the setting of improving course. [1]